(P-1429) Uptake and Series Completion with Pneumococcal Conjugate Vaccine by Social Determinants of Health among Children in the United States

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Amanda C. Miles, MPH (she/her/hers)

Senior Manager, RWE Scientist, Vaccines
Pfizer
New York, NY, United States

XZ

Xin Zhao, MS

Principal Scientist, Biostatistics
Genesis Research Group
Hoboken, New Jersey, United States
CP

Christopher G. Prener, PhD

Pfizer
New York, New York, United States
HL

Huihua Li, MS, MD

Director, Biostatistics
Pfizer, Inc
Collegeville, Pennsylvania, United States
AR

Alison E. Randall, MPH, PMP

Clinical Scientist
Pfizer, Inc.
New York, New York, United States
BA

Benjamin Althouse, PhD

Pfizer
New York, New York, United States
MR

Mark Rozenbaum, PhD, M.B.A.

Global Value & Evidence Team Lead Pneumococcal Vaccines
Pfizer Inc.
Randstad, Noord-Holland, Netherlands
Lindsay Grant, PhD, MPH (she/her/hers)

Senior Director, Evidence Generation Strategist Pneumococcal Vaccines
Pfizer Inc.
Collegeville, PA, United States
RA

Ronika Alexander, M.Ed

US Medical Director for Health Equity
Pfizer
Washington, District of Columbia, United States
PP

Paul Palmer, PhD

Doctor
Pfizer Vaccine Medical Development, Scientific & Clinical Affairs , Collegeville PA
Collegeville, PA, United States
MT

Maria J. Tort, PhD

Pfizer, Inc
Collegeville, Pennsylvania, United States